Page last updated: 2024-08-24

plerixafor and Thrombopenia

plerixafor has been researched along with Thrombopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bhattarai, G; Cho, ES; Kim, MH; Kook, SH; Lee, JC; Poudel, SB; Sim, HJ; So, HS1
Calandra, G; Gandhi, PJ; Jacobsen, ED; Micallef, IN; Shaughnessy, P; Uberti, J; van Rhee, F1

Other Studies

2 other study(ies) available for plerixafor and Thrombopenia

ArticleYear
Local and Systemic Overexpression of COMP-Ang1 Induces Ang1/Tie2-Related Thrombocytopenia and SDF-1/CXCR4-Dependent Anemia.
    Stem cells (Dayton, Ohio), 2023, 01-30, Volume: 41, Issue:1

    Topics: Anemia; Angiopoietin-1; Animals; Cartilage Oligomeric Matrix Protein; Chemokine CXCL12; Mice; Mice, Transgenic; Receptor, TIE-2; Thrombocytopenia

2023
G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.
    Bone marrow transplantation, 2013, Volume: 48, Issue:2

    Topics: Benzylamines; Blood Component Removal; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Leukocyte Count; Leukopenia; Lymphoma, Non-Hodgkin; Multiple Myeloma; Platelet Count; Retrospective Studies; Thrombocytopenia

2013